Caprock Group, Inc. Veracyte, Inc. Transaction History
Caprock Group, Inc.
- $3.21 Billion
- Q1 2025
A detailed history of Caprock Group, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Caprock Group, Inc. holds 6,915 shares of VCYT stock, worth $189,263. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,915
Previous 6,852
0.92%
Holding current value
$189,263
Previous $271,000
24.35%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding VCYT
# of Institutions
301Shares Held
78.1MCall Options Held
15.5KPut Options Held
16.7K-
Vanguard Group Inc Valley Forge, PA8.26MShares$226 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$213 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$143 Million0.27% of portfolio
-
Wellington Management Group LLP Boston, MA3.85MShares$105 Million0.02% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.8MShares$104 Million0.85% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.96B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...